Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
Farmers Insurance
Chubb
Accenture
Federal Trade Commission

Generated: June 16, 2019

DrugPatentWatch Database Preview

Litigation Details for Senju Pharmaceutical Co. Ltd. v. Apotex Inc. (D. Del. 2012)

« Back to Dashboard

Senju Pharmaceutical Co. Ltd. v. Apotex Inc. (D. Del. 2012)

Docket ➤ Try a Free Trial Date Filed 2012-02-10
Court District Court, D. Delaware Date Terminated 2013-10-02
Cause 35:271 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties ALLERGAN INC.; APOTEX CORP.; APOTEX INC.; KYORIN PHARMACEUTICAL CO. LTD.; SENJU PHARMACEUTICAL CO. LTD.
Patents 4,551,456; 4,980,470; 5,880,283; 6,333,045
Attorneys Francis J. Murphy , Jr.; Jack B. Blumenfeld; Maryellen Noreika
Link to Docket External link to docket
Small Molecule Drugs cited in Senju Pharmaceutical Co. Ltd. v. Apotex Inc.
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , and ➤ Try a Free Trial .

Details for Senju Pharmaceutical Co. Ltd. v. Apotex Inc. (D. Del. 2012)

Date Filed Document No. Description Snippet Link To Document
2012-02-10 1 expiration of either the ‘045 Patent or U.S. Patent 5,880,283 (the ‘283 patent). 35. The January 13, 2012… certificate, and United States Patent No. 5,880,283 (“the ‘283 Patent”) under 35 U.S.C. §271(€)(2). T…United States Patent No. 6,333,045 (“the ‘045 Patent”), the claims set forth on the ‘045 Patent reexamination…claim of the ‘045 Patent, the ‘045 Patent reexamination certificate, and the ‘283 Patent has a statutory… Allergan has listed the ‘045 Patent, the ‘283 patent and other patents in the “Approved Drug Products External link to document
2012-02-10 3 Date of Expiration of Patent: 08/20/2019 for 6,333,045 and 12/05/2015 for 5,880,283.Thirty Month Stay Deadline… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2012 2 October 2013 1:12-cv-00159-SLR Patent None District Court, D. Delaware External link to document
2012-02-10 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,333,045 B1; 5,880,283;. (dmp, ) (Entered…2012 2 October 2013 1:12-cv-00159-SLR Patent None District Court, D. Delaware External link to document
2013-02-06 44 licensees of U.S. Patent Nos. 6,333,045 ("the '045 patent") and 5,880,283 ("the '…infringes the '045 and '283 patents (collectively, "the patents-at-issue"). (/d.) …claims 1-3, 6, 8, and 9 of the '045 patent with the U.S. Patent and Trademark Office ("PTO"…claims of a patent are invalid for "fail[ing] to meet the conditions for patentability within the…of the '045 patent, which is publicly available through the PTO's Public Patent Application Information External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
McKesson
Fish and Richardson
Argus Health
Federal Trade Commission
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.